• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Corvus Pharmaceuticals, Inc. - Common Stock (NQ:CRVS)

    8.050 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EST, Jan 16, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 51,214
    Open 8.050
    Bid (Size) 8.100 (800)
    Ask (Size) 8.750 (300)
    Prev. Close 8.050
    Today's Range 8.050 - 8.050
    52wk Range 2.540 - 9.600
    Shares Outstanding 74,681,872
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Earnings Scheduled For November 4, 2025 ↗
     
    Via Benzinga
    News headline image
    Corvus Pharmaceuticals Inc (NASDAQ:CRVS) Reports Narrower-Than-Expected Q2 2025 Loss, Shares Rise on Clinical Progress ↗
    Corvus Pharmaceuticals reported a narrower Q2 2025 loss of $0.10 per share, beating estimates, with shares rising 5.8% after-hours. Positive Phase 1 data for soquelitinib in atopic dermatitis boosted... 
    Via Chartmill

    Performance

    YTD
    +10.0%
    +10.0%
    1 Month
    +3.2%
    +3.2%
    3 Month
    +7.8%
    +7.8%
    6 Month
    +80.9%
    +80.9%
    1 Year
    +54.2%
    +54.2%

    More News

    Read More
    News headline image
    Corvus (CRVS) Q2 Loss Beats Estimates ↗
    Via The Motley Fool
    Topics Intellectual Property
    News headline image
    Earnings Scheduled For August 7, 2025 ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Friday's Intraday Session ↗
    Via Benzinga
    News headline image
    Corvus Gets Price Target Hike From Oppenheimer On Positive Drug Trial Results: Retail’s Pleased ↗
    Via Stocktwits
    News headline image
    Earnings Scheduled For May 8, 2025 ↗
    Via Benzinga
    News headline image
    Earnings Scheduled For November 12, 2024 ↗
    Via Benzinga
    News headline image
    Why Is Corvus Pharmaceuticals Stock Soaring On Friday? ↗
    Via Benzinga
    News headline image
    Wondering what's happening in today's pre-market session? ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Why Pinterest Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket ↗
    Via Benzinga
    News headline image
    Curious about the stocks that are showing activity after the closing bell on Thursday? ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Thursday's After-Market Session ↗
    Via Benzinga
    News headline image
    These stocks are gapping in today's session ↗
    Via Chartmill
    News headline image
    Corvus Pharma Stock Dips On Bigger-Than-Feared Q4 Loss, But Retail’s Faith Grows Stronger ↗
    Via Stocktwits
    News headline image
    Earnings Scheduled For March 25, 2025 ↗
    Via Benzinga
    News headline image
    This Kopin Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Why Is Corvus Pharmaceuticals Stock Trading Lower On Wednesday? ↗
    Via Benzinga
    News headline image
    Crude Oil Gains Over 1%, General Mills Shares Fall ↗
    Via Benzinga
    News headline image
    Dow Surges 150 Points, US Current Account Deficit Widens In Q3 ↗
    Via Benzinga
    Topics Stocks
    News headline image
    Heico, Corvus Pharmaceuticals, Tesla And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    US Stocks To Open Higher As Rate Cut Expectations Surge: All Eyes On Dow Jones To Break Its 9-Day Losing Streak ↗
    Via Benzinga
    Topics Economy Stocks
    News headline image
    Why Corvus Pharmaceuticals Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket ↗
    Via Benzinga

    Frequently Asked Questions

    Is Corvus Pharmaceuticals, Inc. - Common Stock publicly traded?
    Yes, Corvus Pharmaceuticals, Inc. - Common Stock is publicly traded.
    What exchange does Corvus Pharmaceuticals, Inc. - Common Stock trade on?
    Corvus Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Corvus Pharmaceuticals, Inc. - Common Stock?
    The ticker symbol for Corvus Pharmaceuticals, Inc. - Common Stock is CRVS on the Nasdaq Stock Market
    What is the current price of Corvus Pharmaceuticals, Inc. - Common Stock?
    The current price of Corvus Pharmaceuticals, Inc. - Common Stock is 8.050
    When was Corvus Pharmaceuticals, Inc. - Common Stock last traded?
    The last trade of Corvus Pharmaceuticals, Inc. - Common Stock was at 01/16/26 04:00 PM ET
    What is the market capitalization of Corvus Pharmaceuticals, Inc. - Common Stock?
    The market capitalization of Corvus Pharmaceuticals, Inc. - Common Stock is 601.19M
    How many shares of Corvus Pharmaceuticals, Inc. - Common Stock are outstanding?
    Corvus Pharmaceuticals, Inc. - Common Stock has 601M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.